ARTV- Artiva Biotherapeutics, Inc.

Trade Summary

1 week ago, Horan Christopher, serving as Chief Tech Operations Officer at Artiva Biotherapeutics, Inc. (ARTV), sold 10,366 shares at $11.16 per share, for a total transaction value of $115,637.91. Following this transaction, Horan Christopher now holds 283,084 shares of ARTV.

This sale represents a 3.53% decrease in Horan Christopher's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, September 3, 2026 and publicly disclosed via SEC Form 4 filing on Friday, September 4, 2026 at 4:04 PM ET, 1 day after the trade was made.

Artiva Biotherapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.